Cytek Biosciences (CTKB) Enterprise Value (2020 - 2025)
Cytek Biosciences (CTKB) has disclosed Enterprise Value for 6 consecutive years, with -$90.9 million as the latest value for Q4 2025.
- For the quarter ending Q4 2025, Enterprise Value rose 7.99% year-over-year to -$90.9 million, compared with a TTM value of -$90.9 million through Dec 2025, up 7.99%, and an annual FY2025 reading of -$90.9 million, up 7.99% over the prior year.
- Enterprise Value was -$90.9 million for Q4 2025 at Cytek Biosciences, up from -$93.3 million in the prior quarter.
- Across five years, Enterprise Value topped out at -$30000.0 in Q2 2024 and bottomed at -$376.8 million in Q3 2021.
- Average Enterprise Value over 5 years is -$172.4 million, with a median of -$161.7 million recorded in 2021.
- The sharpest move saw Enterprise Value surged 99.99% in 2024, then plummeted 302603.14% in 2025.
- Year by year, Enterprise Value stood at -$364.6 million in 2021, then rose by 17.86% to -$299.5 million in 2022, then soared by 44.03% to -$167.6 million in 2023, then surged by 41.09% to -$98.7 million in 2024, then rose by 7.99% to -$90.9 million in 2025.
- Business Quant data shows Enterprise Value for CTKB at -$90.9 million in Q4 2025, -$93.3 million in Q3 2025, and -$75.5 million in Q2 2025.